As illustrated in Figs. 6A–6E, expression levels of TRIP13, TPX2, DLGAP5, KIF2C and TTK were associated with shorter disease free survival (DFS) among differentiated thyroid cancer. This evidence concerns the gene KIF2C and thyroid cancer.